Central and deep renal tumors can be effectively ablated: Radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring

Journal of Endourology

Volumn 22, Issue 6, 2008, Pages 1261-1267

  Wingo, Marshall S ^a,b   Leveillee, Raymond J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Lowcountry Urology Clinics PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FIBER OPTICS; HUMAN; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY; CATHETER ABLATION; DEMOGRAPHY; FEMALE; FIBER OPTICS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TEMPERATURE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 46249110529     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.0135     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185:64-71.
3. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003;226:417-424.
4. Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, Mc-Dougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: Early clinical experience. Radiology 2000; 217:665-672.
5. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003;180:1509-1513.
6. Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, Chen MY. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: Factors influencing success. AJR Am J Roentgenol 2004;183:201-207.
7. Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: Preliminary results. Urology 2003;61(suppl 1):26-33.
8. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzello JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: Techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003;180:1503-1508.
9. Pavlovich CP, Walther MM, Choyke PL, Pautler SE, Chang R, Linehan WM, Wood BJ. Percutaneous radio frequency ablation of small renal tumors: Initial results. J Urol 2002;167:10-15.
10. Ogan K, Jacomides L, Dolmatch B L, Rivera FJ, Dellaria MF, Josephs SC, Cadeddu JA. Percutaneous radiofrequency blation ablation of renal tumors: Technique, limitations, and morbidity. Urology 2002;60:954-958.
11. Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ. Early experience with percutaneous radiofrequency of small solid renal masses. AJR Am J Roentgenol 2003;180:1055-1061.
12. Lele P.Thresholds and mechanisms of ultrasonic damage to organized animal tissues. Presented at the Symposium on Biological Effects and Characterizations of Ultrasound Sources. Rockville, Md, 1977.
13. Djavan B, Zlotta AR, Susani M, Heinz G, Shariat S, Silverman DE, Schulman CC, Marberger M. Transperineal radiofrequency interstitial tumor ablation of the prostate: Correlation of magnetic resonance imaging with histopathologic examination. Urology 1997;50:986-993.
14. Bhowmick S, Swanlund DJ, Coad JE, Luloff L, Hoey MF, Bischof JC. Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe. J Endourol 2001;15:629-640.
15. McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992;3:291-297.
16. Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: Physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 2001;48:359-367.
17. Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology 2006;240:82-89.
18. Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: Protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol 2005;16: 1551-1555.
19. Horkan C, Ahmed M, Liu Z, Gazelle GS, Solazzo SA, Kruskal JB, Goldberg SN. Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol 2004;15:269-274.
20. Leveillee RJ, Hoey MF. Radiofrequency interstitial tissue ablation: Wet electrode. J Endourol 2003;17:563-577.